By IDSE News Staff
A vaccine for eastern equine encephalitis (EEE), western equine encephalitis (WEE) and Venezuelan equine encephalitis (VEE) viruses was found to be safe, well tolerated and induced a neutralizing antibody response in adult volunteers, according to newly published results from a phase 1 clinical trial (Lancet Infect Dis 2022 May 11. doi:10.1016/S1473-3099(22)00052-4).
For the trial, 30 healthy adult volunteers between 18 and 50 years of age received varying doses of the